BIOMAT Database Logo BIOMAT Database Logo

[Study of neutral 17-ketosteroid fractions in the urine in various diseases]. 1963

O KOREF, and T FEHER, and I HOLLO

UI MeSH Term Description Entries
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal
D015068 17-Ketosteroids Steroids that contain a ketone group at position 17. 17-Oxosteroids,17 Ketosteroids,17 Oxosteroids
D047808 Adrenogenital Syndrome Abnormal SEX DIFFERENTIATION or congenital DISORDERS OF SEX DEVELOPMENT caused by abnormal levels of steroid hormones expressed by the GONADS or the ADRENAL GLANDS, such as in CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children. Adrenogenital Syndromes,Syndrome, Adrenogenital,Syndromes, Adrenogenital

Related Publications

O KOREF, and T FEHER, and I HOLLO
[Studies on neutral 17-ketosteroids. II. Study on neutral 17-ketosteroid fractions in human urine].
July 1957, Kiserletes orvostudomany,
O KOREF, and T FEHER, and I HOLLO
[The excretion of neutral 17-ketosteroid fractions in the urine of normal girls].
November 1967, Maandschrift voor kindergeneeskunde,
O KOREF, and T FEHER, and I HOLLO
[Determination of 17-ketosteroid fractions in urine].
January 1966, Endokrynologia Polska,
O KOREF, and T FEHER, and I HOLLO
[17-ketosteroid fractions in urine of male diabetic patients].
June 1967, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
O KOREF, and T FEHER, and I HOLLO
[Research on the excretion of neutral 17-ketosteroid fractions in urine of healthy women and of those with liver diseases. II].
August 1957, Arztliche Wochenschrift,
O KOREF, and T FEHER, and I HOLLO
[Studies on neutral 17-ketosteroids. III. Neutral 17-ketosteroid fractions in active and inactive stages of ulcerous disease].
February 1958, Magyar belorvosi archivum (1955),
O KOREF, and T FEHER, and I HOLLO
[The excretion of neutral 17-ketosteroid fractions in the urine of healthy and hepatopathic men after hydrochloric acid and fermentative hydrolysis].
July 1956, Arztliche Wochenschrift,
O KOREF, and T FEHER, and I HOLLO
[Significance of single fraction, neutral 17-ketosteroid determination in liver diseases].
January 1975, Acta medica Iugoslavica,
O KOREF, and T FEHER, and I HOLLO
[17-Ketosteroid fractions in puerperal hypopituarism].
May 1963, Magyar noorvosok lapja,
O KOREF, and T FEHER, and I HOLLO
[Studies on neutral 17-ketosteroids. I. Simple 17-ketosteroid determination in human and dog urine].
July 1956, Kiserletes orvostudomany,
Copied contents to your clipboard!